Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1

Abstract

Autosomal dominant polycystic kidney disease is an important cause of end-stage renal disease, for which there is no proven therapy1. Mutations in PKD1 (the gene encoding polycystin-1) are the principal cause of this disease. The disease begins in utero2 and is slowly progressive, but it is not known whether cystogenesis is an ongoing process during adult life. We now show that inactivation of Pkd1 in mice before postnatal day 13 results in severely cystic kidneys within 3 weeks, whereas inactivation at day 14 and later results in cysts only after 5 months. We found that cellular proliferation was not appreciably higher in cystic specimens than in age-matched controls, but the abrupt change in response to Pkd1 inactivation corresponded to a previously unrecognized brake point during renal growth and significant changes in gene expression. These findings suggest that the effects of Pkd1 inactivation are defined by a developmental switch that signals the end of the terminal renal maturation process. Our studies show that Pkd1 regulates tubular morphology in both developing and adult kidney, but the pathologic consequences of inactivation are defined by the organ's developmental status. These results have important implications for clinical understanding of the disease and therapeutic approaches.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Time of inactivation determines renal response to acquired Pkd1 loss.
Figure 2: Susceptibility to rapid-onset cystic disease switches off between P12 and P14.
Figure 3: Abrupt brake point in rate of renal proliferation parallels marked changes in gene expression.

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Boucher, C. & Sandford, R. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2). Eur. J. Hum. Genet. 12, 347–354 (2004).

    Article  CAS  Google Scholar 

  2. Pretorius, D.H. et al. Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant. J. Ultrasound Med. 6, 249–255 (1987).

    Article  CAS  Google Scholar 

  3. Piontek, K.B. et al. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J. Am. Soc. Nephrol. 15, 3035–3043 (2004).

    Article  Google Scholar 

  4. Lu, W. et al. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation. Nat. Genet. 17, 179–181 (1997).

    Article  CAS  Google Scholar 

  5. Bukanov, N.O., Smith, L.A., Klinger, K.W., Ledbetter, S.R. & Ibraghimov-Beskrovnaya, O. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 444, 949–952 (2006).

    Article  CAS  Google Scholar 

  6. Lanoix, J., D'Agati, V., Szabolcs, M. & Trudel, M. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene 13, 1153–1160 (1996).

    CAS  PubMed  Google Scholar 

  7. Woo, D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N. Engl. J. Med. 333, 18–25 (1995).

    Article  CAS  Google Scholar 

  8. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25–29 (2000).

    Article  CAS  Google Scholar 

  9. Chotteau-Lelievre, A. et al. PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro. Dev. Biol. 259, 241–257 (2003).

    Article  CAS  Google Scholar 

  10. Grantham, J.J., Geiser, J.L. & Evan, A.P. Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int. 31, 1145–1152 (1987).

    Article  CAS  Google Scholar 

  11. Nadasdy, T. et al. Proliferative activity of cyst epithelium in human renal cystic diseases. J. Am. Soc. Nephrol. 5, 1462–1468 (1995).

    CAS  PubMed  Google Scholar 

  12. Chang, M.Y. et al. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. Nephrol. Dial. Transplant. 21, 2078–2084 (2006).

    Article  CAS  Google Scholar 

  13. Shillingford, J.M. et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl. Acad. Sci. USA 103, 5466–5471 (2006).

    Article  CAS  Google Scholar 

  14. Sweeney, W.E. Jr. et al. Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. Kidney Int. 64, 1310–1319 (2003).

    Article  CAS  Google Scholar 

  15. Muskhelishvili, L., Latendresse, J.R., Kodell, R.L. & Henderson, E.B. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67 (MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J. Histochem. Cytochem. 51, 1681–1688 (2003).

    Article  CAS  Google Scholar 

  16. Simons, M. et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat. Genet. 37, 537–543 (2005).

    Article  CAS  Google Scholar 

  17. Fischer, E. et al. Defective planar cell polarity in polycystic kidney disease. Nat. Genet. 38, 21–23 (2006).

    Article  CAS  Google Scholar 

  18. Ciruna, B., Jenny, A., Lee, D., Mlodzik, M. & Schier, A.F. Planar cell polarity signalling couples cell division and morphogenesis during neurulation. Nature 439, 220–224 (2006).

    Article  CAS  Google Scholar 

  19. Torres, V.E. et al. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat. Med. 10, 363–364 (2004).

    Article  CAS  Google Scholar 

  20. Wu, G. et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93, 177–188 (1998).

    Article  CAS  Google Scholar 

  21. Osathanondh, V. & Potter, E.L. Pathogenesis of polycystic kidneys. Historical Survey. Arch. Pathol. 77, 459–465 (1964).

    CAS  PubMed  Google Scholar 

  22. Heggo, O. A microdissection study of cystic disease of the kidneys in adults. J. Pathol. Bacteriol. 91, 311–315 (1966).

    Article  CAS  Google Scholar 

  23. Baert, L. Hereditary polycystic kidney disease (adult form): a microdissection study of two cases at an early stage of the disease. Kidney Int. 13, 519–525 (1978).

    Article  CAS  Google Scholar 

  24. Calvet, J.P. Injury and development in polycystic kidney disease. Curr. Opin. Nephrol. Hypertens. 3, 340–348 (1994).

    Article  CAS  Google Scholar 

  25. Nauli, S.M. et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33, 129–137 (2003).

    Article  CAS  Google Scholar 

  26. Davenport, J.R. et al. Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr. Biol. 17, 1586–1594 (2007).

    Article  CAS  Google Scholar 

  27. Gentleman, R.C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).

    Article  Google Scholar 

  28. Smyth, G. LIMMA: linear models for microarray data. in Bioinformatics and Computational Biology Solutions Using R and Bioconductor (Eds. Gentleman, R., Carey, V.J., Huber, W., Irizarry, R.A., Dudoit, S.) 397–420 (Springer, New York City, 2005).

    Chapter  Google Scholar 

  29. Stegmann, A. et al. Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNF-4 as a central regulator of gene expression during enterocyte differentiation. Physiol. Genomics 27, 141–155 (2006).

    Article  CAS  Google Scholar 

  30. Dennis, G., Jr. et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4, P3 (2003).

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the US National Institutes of Health (DK48006, DK51259) and the US National Kidney Foundation (L.F.M.). G.G.G. is the Irving Blum Scholar of the Johns Hopkins University School of Medicine. The authors wish to thank members of the Germino, Watnick, Montell, Qian and Sutters laboratories (Johns Hopkins University School of Medicine), A. Tousson (University of Alabama at Birmingham) and S. Kuo (Johns Hopkins University School of Medicine) for helpful advice, C. Cheadle (Johns Hopkins Bayview Medical Campus Genomics Core) for assistance with the microarray studies, and M. Knepper (US National Institutes of Health) and J. Hoyer (Children's Hospital of Philadelphia) for the antibodies to aquaporin-2 and Tamm-Horsfall glycoprotein, respectively.

Author information

Authors and Affiliations

Authors

Contributions

K.P. designed and performed the experiments and contributed to the writing of the manuscript. L.F.M. assisted in the experimental design, helped to analyze the histopathology, performed the microarray analyses and assisted in the writing of the manuscript. M.A.G.-G. helped perform the experiments and contributed conceptually to the project. D.L.H. helped with the histopathology. G.G.G. directed the project and wrote the manuscript.

Corresponding author

Correspondence to Gregory G Germino.

Supplementary information

Supplementary Text and Figures

Supplementary Figs. 1–3 and Supplementary Table 1 (PDF 1484 kb)

Supplementary Tables 2–5

Supplementary Tables 2–5 (XLS 220 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piontek, K., Menezes, L., Garcia-Gonzalez, M. et al. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med 13, 1490–1495 (2007). https://doi.org/10.1038/nm1675

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1675

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing